PIVOTAL THERAPEUTICS INC.

Inactive Instrument

Highlights Pivotal Therapeutics Inc. Other OTC

Equities

PVTTF

CA72582E1043

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ford Teams with Pivotal to Speed Development of Connected Car Experiences Capitalizing on New Ford Sync Connect	15/12/15	CI
Pivotal Therapeutics Inc. Executes International Distribution Agreement with Healthcore Co. Ltd	30/11/15	CI
Pivotal Therapeutics Inc. Announces Earnings Results for the Nine Months Ended September 30, 2015	30/11/15	CI
Pivotal Therapeutics Inc. Announces Financial Results for the Six Months Ended June 30, 2015	29/08/15	CI
Pivotal Therapeutics Inc. Announces the Enrollment of the First Patient in Pivotal's POMEGA Phase IIa Clinical Trial with PVT-100	04/06/15	CI
Pivotal Therapeutics Inc. Announces Audited Consolidated Earnings Results for the Three Months Ended March 31, 2015	03/06/15	CI
Pivotal Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2014	01/05/15	CI
Pivotal Therapeutics Inc. Receives Health Canada Approval to Expand the Indication of Omazen	27/04/15	CI
Pivotal Therapeutics Inc. Executes Memorandum of Understanding for Distribution of Benefishial Line of Products in Korea	15/04/15	CI
Pivotal Therapeutics Inc. Receives Final Approval for Phase IIa Clinical Trial with PVT-100	27/01/15	CI
Pivotal Therapeutics Inc. Announces Earnings Results for the Three Months Ended September 30, 2014	28/11/14	CI
Pivotal Therapeutics Inc. Announces Publication of Results of a Prospective Randomized Controlled Trial in the U.S	09/09/14	CI
Pivotal Therapeutics Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2014	27/08/14	CI
Vmware, Inc. Announces Joint Initiatives with Docker, Google and Pivotal to Help Enterprises Run and Manage Container-Based Applications on a Common Platform	25/08/14	CI
Pivotal Therapeutics Inc. Reports Audited Consolidated Earnings Results for the First Quarter Ended March 31, 2014	30/05/14	CI
LucidWorks Certifies on Pivotal to Accelerate Smarter Data Driven Applications with the Power of Enterprise Search	03/02/14	CI
Pivotal Therapeutics Inc Announces Notice of Allowance for U.S. Patent on its Unique 6:1 Epa:Dha Formulation	28/01/14	CI
Pivotal Therapeutics Inc. Presents Positive, Statistically Significant, Top-Line Results from VASCAZEN®-Reveal Trial for its Product VASCAZEN	07/05/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer